Skip to content
Neminath Traders
ListedSME IPO

Himalaya Nutravedics IPO

Himalaya Nutravedics opens for subscription on 22 Sept 2026 and closes on 24 Sept 2026, at a price band of ₹100 – ₹106 with a lot of 2400 shares. Listing is expected on 29 Sept 2026.

Updated 22 Oct 2026

Important dates

  1. Opens

    22 Sept 2026

  2. Closes

    24 Sept 2026

  3. Allotment

    25 Sept 2026

  4. Listing

    29 Sept 2026

IPO details

Price band₹100 – ₹106
Lot size2400 shares
Minimum investment₹2,54,400
Issue size₹26.5 crore
Face value₹10 per share
BoardSME
Listing atBSE SME
Retail quota35%
EPS₹12.05
RoNW45.12%

Grey market premium (GMP)

No meaningful grey market premium was reported at the last update.

GMP is unregulated grey market chatter, not an exchange price, and it often swings or turns out wrong on listing day. SEBI cautions investors against relying on it. Read the GMP explainer.

Subscription status

Subscribed 2.33 times overall at the last update.

DayQIBNIIRetailTotal
Day 10×0.14×0.16×0.11×
Day 20×0.32×0.67×0.4×
Day 31×3.58×2.56×2.33×

Company financials (₹ crore)

YearRevenueExpensesProfit after tax
FY2414.4313.830.43
FY252118.752.23
FY2643.1235.647.39

About Himalaya Nutravedics

Founded in 2022, Himalaya Nutravedics is an Ayurvedic and nutraceutical manufacturing firm involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.

The firm sells its products under its own brands and also sells them through doctors, hospitals, clinics, pharmacists, or other healthcare professionals. The firm has expanded its portfolio across 17 states and one union territory in India. Moreover, its manufacturing facility is located at is located in Hyderabad, Telangana, and holds WHO-GMP certifications. Its competitive strengths are strong relationships with suppliers and customers and Integrated multi-dosage manufacturing capability.

Objects of the issue

  • Funding Working Capital Requirements
  • Business Development and Digital Marketing Activities
  • General Corporate Purposes

Allotment status and registrar

Kfin Technologies Ltd. is the registrar. After 25 Sept 2026, check your status with your PAN or application number on the registrar's site or the BSE/NSE allotment pages.

Registrar contact: 040-79615565 · himalaya.ipo@kfintech.com

Lead managers and offer documents

  • Nirbhay Capital Services Pvt. Ltd.

Himalaya Nutravedics IPO: FAQs

When does the Himalaya Nutravedics IPO open and close?

The Himalaya Nutravedics IPO opens on 22 Sept 2026 and closes on 24 Sept 2026.

What is the Himalaya Nutravedics IPO price band?

The price band is ₹100 – ₹106 per share (face value ₹10).

What is the Himalaya Nutravedics IPO lot size?

One lot is 2400 shares, so the minimum investment is ₹2,54,400 at the upper price band.

When is the Himalaya Nutravedics IPO allotment date?

Allotment is expected on 25 Sept 2026. Check the status on the registrar's site (Kfin Technologies Ltd.) or the BSE/NSE allotment pages using your PAN.

When will Himalaya Nutravedics shares list?

Listing is expected on 29 Sept 2026 on BSE SME.

What is the Himalaya Nutravedics IPO GMP today?

No meaningful grey market premium was reported when this page was last updated. GMP is unofficial and unregulated, so it should not drive your decision.

Details are compiled from the offer documents and exchange disclosures via IPOWatch and may change or contain errors; verify in the RHP and on BSE/NSE before applying. This page is for information only and is not a recommendation to apply. Neminath Traders is not a SEBI-registered investment adviser. Read how to apply for an IPO.

Other IPOs

*GMP (grey market premium) is an unofficial, unregulated indicator of demand, not a guarantee of listing price. SEBI cautions investors against relying on grey market activity. Educational information only, not investment advice.

IPOs around the same time

All IPOs →